Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone for threatened miscarriage at University of Ilorin Teaching Hospital
PACTR202602897060718Phase 4Not yet recruiting
- Sponsor
- Dr Aboyeji Oluwasegun Olaosebikan
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dydrogesterone in threatened abortion (2 arms), sponsored by Dr Aboyeji Oluwasegun Olaosebikan. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
dydrogesterone
03
Conditions
threatened abortion
Beyond the preview
Go deeper on PACTR202602897060718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202602897060718.